Similar finding were reported for BCMA-CAR T cells [21, 22] and CD19-CAR T cells [16, 19], showing that CAR T cells produced from less differentiated T cells possess greater anti-tumor activity and proliferation potential. Here, TNFRSF17 is linked to neoplasm.